Novartis AG (NVS)
97.32
+2.20
(+2.31%)
USD |
NYSE |
Apr 23, 16:00
97.24
-0.08
(-0.08%)
After-Hours: 20:00
Novartis Gross Profit Margin (Quarterly): 74.34% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 74.34% |
| September 30, 2023 | 74.22% |
| June 30, 2023 | 68.85% |
| March 31, 2023 | 70.24% |
| December 31, 2022 | 72.27% |
| September 30, 2022 | 73.35% |
| June 30, 2022 | 71.33% |
| March 31, 2022 | 69.91% |
| December 31, 2021 | |
| September 30, 2021 | 70.54% |
| June 30, 2021 | 70.56% |
| March 31, 2021 | 68.18% |
| December 31, 2020 | 67.64% |
| September 30, 2020 | 70.07% |
| June 30, 2020 | 70.50% |
| March 31, 2020 | 70.71% |
| December 31, 2019 | 68.61% |
| September 30, 2019 | 69.75% |
| June 30, 2019 | 71.67% |
| March 31, 2019 | 71.62% |
| December 31, 2018 | 66.06% |
| September 30, 2018 | 69.59% |
| June 30, 2018 | 69.47% |
| March 31, 2018 | 69.09% |
| December 31, 2017 | 85.28% |
| Date | Value |
|---|---|
| September 30, 2017 | 65.94% |
| June 30, 2017 | 65.92% |
| March 31, 2017 | 65.17% |
| December 31, 2016 | 64.39% |
| September 30, 2016 | 64.61% |
| June 30, 2016 | 64.89% |
| March 31, 2016 | 64.34% |
| December 31, 2015 | 64.47% |
| September 30, 2015 | 64.85% |
| June 30, 2015 | 65.21% |
| March 31, 2015 | 67.38% |
| December 31, 2014 | 66.93% |
| September 30, 2014 | 66.76% |
| June 30, 2014 | 68.61% |
| March 31, 2014 | 68.31% |
| December 31, 2013 | 67.51% |
| September 30, 2013 | 68.03% |
| June 30, 2013 | 69.22% |
| March 31, 2013 | 67.58% |
| December 31, 2012 | 76.82% |
| September 30, 2012 | 67.41% |
| June 30, 2012 | 68.30% |
| March 31, 2012 | 67.77% |
| December 31, 2011 | 65.87% |
| September 30, 2011 | 68.15% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
67.64%
Minimum
Dec 2020
74.34%
Maximum
Dec 2023
70.71%
Average
70.52%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Sandoz Group AG | -- |
| Roche Holding AG | -- |
| Amgen Inc | 62.03% |
| Incyte Corp | 93.11% |
| MorphoSys AG | 75.20% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 29.93% |
| Return on Assets | 13.42% |
| Return on Invested Capital | 19.72% |
| Profit Margin (Quarterly) | 72.01% |
| Operating Margin (Quarterly) | 21.93% |
| Return on Net Operating Assets | 17.50% |